Viking Therapeutics, Inc. (VKTX) Operating Lease, Right-of-Use Asset USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Viking Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2024.
  • Viking Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $1.05 M, a 21.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.05 M -$294 K -21.8% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $1.13 M -$292 K -20.6% Dec 31, 2023 10-Q 2024-04-25
Q3 2023 $1.2 M -$289 K -19.4% Sep 30, 2023 10-Q 2023-10-25
Q2 2023 $1.27 M -$287 K -18.4% Jun 30, 2023 10-Q 2023-07-26
Q1 2023 $1.35 M -$286 K -17.5% Mar 31, 2023 10-Q 2023-04-26
Q4 2022 $1.42 M +$1.39 M +5572% Dec 31, 2022 10-K 2024-02-07
Q3 2022 $1.49 M +$1.39 M +1374% Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $1.56 M +$1.38 M +786% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $1.63 M +$1.38 M +555% Mar 31, 2022 10-Q 2022-04-27
Q4 2021 $25 K -$296 K -92.2% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $101 K -$291 K -74.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $176 K -$286 K -61.9% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $249 K -$281 K -53% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $321 K -$277 K -46.3% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $392 K -$272 K -41% Sep 30, 2020 10-Q 2020-10-28
Q2 2020 $462 K -$268 K -36.7% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $530 K -$264 K -33.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $598 K Dec 31, 2019 10-K 2021-02-17
Q3 2019 $664 K Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $730 K Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $794 K Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.